To molecularlyestablish a causal role of ATG12-driven autophagy in the de novo resistance ofHER2 gene-amplified breast cancer cells to trastuzumab, we employed alentivirus-mediated stable knockdown of the ATG12 gene. Here, ATG12 is linked to breast carcinoma.